PTGS2 and non-small cell lung carcinoma: In a retrospective analysis of 100 patients who had undergone a complete resection for NSCLC, the authors evaluated the prognostic utility of the combination of epithelial Cyclooxygenase-2 (COX-2) expression and tumor-infiltrating Tregs.